Effect of Brovincamine fumarate on vertigo or dizziness

Abstract

Forty-six patients with vertigo or dizziness were administered three Sabromin Tablets (R)(each containing 25.36 mg of Brovincamine fumarate) daily, with or without other remedies for motion sickness, for 4 to 8 weeks. The following results were obtained. The therapy was markedly effective for 50% of the patients and fairly effective for 33%. There were no differences in effectiveness between central and peripheral vestibular diseases, nor between acute and chronic diseases. Acute symptoms like vertigo, nausea, vomiting and palpitation were cured very successfully with the therapy. Chronic symptoms remaining after acute attacks, like tinnitus or stiffness of the neck or shoulders, were also cured to a certain but lesser extent. We concluded that Brovincamine fumarate should be effective not only for symptoms caused by decreased cerebrovascular blood flow but also for those caused by peripheral vestibular dysfunction.